.svg)
The Texas Heart Institute Biorepository Demonstrates Excellence in Sample Quality with New Publication
A Study Validates THI’s Biorepository as a Global Leader in Long-Term Sample Preservation and Quality Assurance The Texas Heart Institute...
Biorepository and Biospecimen Profiling Core
The Texas Heart Institute Research Symposium: Cutting-Edge Innovations Driving Translational Clinical Care
HOUSTON (Oct. 27, 2023) — Renowned scientists and clinicians from The Texas Heart Institute gathered this week for its inspiring,...
The Texas Heart Institute Makes a Strong Showing at ISHLT 2023
Daniel Timms, PhD, founder and chief technical officer of BiVACOR, Inc., described the benchtop testing and preclinical studies performed with...
The Texas Heart Institute Biorepository Core Reaccredited by the College of American Pathologists
The Texas Heart Institute Biorepository and Biospecimen Profiling Core Laboratory has been reaccredited by the College of American Pathologists (CAP)...
The Texas Heart Institute Research Symposium 2022: A Day to Celebrate Innovation, Collaboration, and Translation
During its annual day-long Research Symposium on October 20, 2022, The Texas Heart Institute community came together in the Denton...
Improving Outcomes After Cell Therapy May Be Linked to Patient Characteristics
Investigators at The Texas Heart Institute (THI) have gained new insights into patient-related factors that may affect clinical outcomes after...
THI Biorepository Awarded Equipment Grant for Automated Cryopreservation System
HOUSTON (September 14, 2022) — The Texas Heart Institute (THI) Biorepository and Biospecimen Profiling Core Laboratory has received an R24...
